Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that Dr. Kevin Rodan Levy, its Chief Executive Officer, plans to attend HLTH Europe 2026. The international healthcare conference, scheduled from June 15-18 in Amsterdam, focuses on digital health, healthcare innovation, and emerging technologies.
Dr. Levy’s attendance is part of the Company’s broader strategic initiatives to engage with healthcare industry participants, evaluate emerging technologies, and explore strategic relationships that may support the development and expansion of its digital health ecosystem. The Company believes that participation in major international conferences provides valuable opportunities to observe industry developments, strengthen professional networks, and advance its telehealth and artificial intelligence platform strategy.
HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from global markets to discuss healthcare transformation, digital infrastructure, and advancements in healthcare delivery. This environment offers Catalyst Crew Technologies opportunities to observe industry trends and engage with broader healthcare innovation movements.
Dr. Levy stated: “As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning.”
The Company continues to develop its telehealth platform infrastructure, artificial intelligence healthcare modules, and broader digital health strategy across Latin America and emerging markets. For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Catalyst Crew Technologies Corp. is an AI-driven healthcare technology company focused on scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is executing a strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
